Cancer evaluation drug screening assays antitumor. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy16

Cell Line, Tumor Tumor Cells, Cultured HT29 Cells Neoplastic Stem Cells HCT116 Cells T-Lymphocytes, Cytotoxic Lymphocytes, Tumor-Infiltrating Breast CD8-Positive T-Lymphocytes Dendritic Cells Cell Line Killer Cells, Natural MCF-7 Cells Prostate Lymph Nodes T-Lymphocytes

Organisms7

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL Adenoviridae Oncolytic Viruses Mice, Transgenic

Diseases55

Neoplasms Lung Neoplasms Colonic Neoplasms Ovarian Neoplasms Prostatic Neoplasms Breast Neoplasms Neoplasms, Experimental Neoplasm Metastasis Stomach Neoplasms Pancreatic Neoplasms Neoplasm Invasiveness Leukemia P388 Melanoma, Experimental Sarcoma 180 Carcinoma Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Uterine Cervical Neoplasms Urinary Bladder Neoplasms Colorectal Neoplasms Disease Progression Genetic Predisposition to Disease Neovascularization, Pathologic Melanoma Leukemia L1210 Adenocarcinoma Mammary Neoplasms, Experimental Liver Neoplasms Neoplasm Recurrence, Local Rectal Neoplasms Cell Transformation, Neoplastic Head and Neck Neoplasms Endometrial Neoplasms Esophageal Neoplasms Skin Neoplasms Bone Neoplasms Kidney Neoplasms Cystadenoma Carcinoma, Small Cell Neoplasms, Hormone-Dependent Disease Models, Animal Mouth Neoplasms Fibrosarcoma Neoplasms, Glandular and Epithelial Carcinoma, Lewis Lung Sarcoma, Experimental Genital Neoplasms, Female Neoplasms, Radiation-Induced Gastrointestinal Neoplasms Brain Neoplasms Neoplasms, Second Primary Thyroid Neoplasms Precancerous Conditions Carcinoma, Hepatocellular Lymphoma

Chemicals and Drugs59

Antineoplastic Agents Cancer Vaccines Antibiotics, Antineoplastic Neoplasm Proteins Antineoplastic Agents, Phytogenic Antigens, Neoplasm Antibodies, Monoclonal Cisplatin Receptor, erbB-2 RNA, Messenger Fluorouracil DNA, Neoplasm Tumor Markers, Biological Receptors, Estrogen Paclitaxel RNA, Small Interfering Tumor Suppressor Protein p53 Prostate-Specific Antigen Receptor, Epidermal Growth Factor Deoxycytidine Tamoxifen Camptothecin Antimetabolites, Antineoplastic Taxoids Protein Kinase Inhibitors Enediynes Anticarcinogenic Agents Quinazolines Antineoplastic Agents, Hormonal Antibodies, Monoclonal, Humanized Receptors, Progesterone Enzyme Inhibitors Indoles RNA, Neoplasm Organoplatinum Compounds Tumor Suppressor Proteins Proto-Oncogene Proteins c-akt Antibodies, Neoplasm MicroRNAs Cyclophosphamide Prodrugs DNA-Binding Proteins Carcinoembryonic Antigen Immunotoxins Antineoplastic Agents, Alkylating Proto-Oncogene Proteins Receptors, Androgen Vascular Endothelial Growth Factor A Proto-Oncogene Proteins c-bcl-2 Plant Extracts Interferon-gamma Transcription Factors Recombinant Proteins Carcinogens Angiogenesis Inhibitors Nuclear Proteins Interleukin-2 Androgens BRCA2 Protein

Analytical, Diagnostic and Therapeutic Techniques and Equipment68

Xenograft Model Antitumor Assays Drug Screening Assays, Antitumor Early Detection of Cancer Neoplasm Transplantation Neoplasms, Experimental Antineoplastic Combined Chemotherapy Protocols Melanoma, Experimental Transplantation, Heterologous Immunotherapy Survival Analysis Survival Rate Tumor Burden Combined Modality Therapy Reverse Transcriptase Polymerase Chain Reaction Prognosis Blotting, Western Gene Expression Profiling Genetic Therapy Follow-Up Studies Risk Retrospective Studies Neoplasm Staging Mammary Neoplasms, Experimental Immunotherapy, Adoptive Flow Cytometry Registries Prospective Studies Disease-Free Survival Drug Administration Schedule Risk Assessment Transfection Inhibitory Concentration 50 Odds Ratio Chemotherapy, Adjuvant Molecular Targeted Therapy Clinical Trials as Topic Kaplan-Meier Estimate Injections, Intralesional Sensitivity and Specificity Oligonucleotide Array Sequence Analysis Treatment Outcome Disease Models, Animal Drug Delivery Systems Multivariate Analysis Mammography Polymerase Chain Reaction Risk Factors Questionnaires SEER Program Sarcoma, Experimental Models, Biological Immunohistochemistry Immunoenzyme Techniques Radiotherapy Oncolytic Virotherapy Predictive Value of Tests Drug Evaluation, Preclinical Reproducibility of Results Gene Knockdown Techniques Logistic Models Tissue Array Analysis Confidence Intervals Neoplasm Grading Tumor Stem Cell Assay Administration, Oral Enzyme-Linked Immunosorbent Assay Incidence Palliative Care

Psychiatry and Psychology1

Phenomena and Processes46

Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Apoptosis Cell Proliferation Cell Survival Dose-Response Relationship, Drug Drug Synergism Cell Division Genetic Predisposition to Disease Mutation Risk Cell Cycle Cell Growth Processes Down-Regulation Cell Movement Transfection Inhibitory Concentration 50 DNA Methylation Odds Ratio Signal Transduction Sensitivity and Specificity Genetic Vectors Cytotoxicity, Immunologic Genotype Promoter Regions, Genetic Genes, BRCA1 RNA Interference Gene Expression Tumor Microenvironment Phosphorylation Gene Silencing Polymorphism, Genetic Base Sequence Time Factors Genes, Tumor Suppressor Phenotype Genes, p53 Tumor Escape DNA Damage Germ-Line Mutation Genes, Neoplasm Diet Postmenopause Cell Death Structure-Activity Relationship Genes, BRCA2

Disciplines and Occupations2

Medical Oncology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Molecular Sequence Data Questionnaires SEER Program Base Sequence Incidence

Named Groups1

Health Care27

Survival Analysis Survival Rate National Cancer Institute (U.S.)Follow-Up Studies Risk Retrospective Studies Registries Prospective Studies Disease-Free Survival Risk Assessment Odds Ratio Age Factors Clinical Trials as Topic Kaplan-Meier Estimate Sensitivity and Specificity Treatment Outcome Multivariate Analysis Risk Factors Questionnaires SEER Program American Cancer Society Predictive Value of Tests Reproducibility of Results Logistic Models Confidence Intervals Incidence Palliative Care

Geographicals3

United States Japan China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Xenograft Model Antitumor Assays Drug Screening Assays, Antitumor Antineoplastic Agents Mice, Nude Early Detection of Cancer Cell Line, Tumor Cancer Vaccines Neoplasms Lung Neoplasms Neoplasm Transplantation Colonic Neoplasms Ovarian Neoplasms Prostatic Neoplasms Breast Neoplasms Antibiotics, Antineoplastic Neoplasms, Experimental Neoplasm Metastasis Stomach Neoplasms Pancreatic Neoplasms Tumor Cells, Cultured Gene Expression Regulation, Neoplastic Neoplasm Invasiveness Leukemia P388 Mice, Inbred BALB C Antineoplastic Combined Chemotherapy Protocols Melanoma, Experimental Neoplasm Proteins Transplantation, Heterologous Immunotherapy Sarcoma 180 Drug Resistance, Neoplasm Apoptosis Antineoplastic Agents, Phytogenic Antigens, Neoplasm Cell Proliferation Cell Survival Mice, SCID Dose-Response Relationship, Drug Survival Analysis Drug Synergism Survival Rate Carcinoma Tumor Burden Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Combined Modality Therapy Uterine Cervical Neoplasms Antibodies, Monoclonal Urinary Bladder Neoplasms Reverse Transcriptase Polymerase Chain Reaction Cell Division Colorectal Neoplasms Cisplatin Disease Progression Receptor, erbB-2 Mice, Inbred C57BL Prognosis Blotting, Western Genetic Predisposition to Disease RNA, Messenger Neovascularization, Pathologic Melanoma National Cancer Institute (U.S.)Fluorouracil Mutation Gene Expression Profiling DNA, Neoplasm Genetic Therapy Follow-Up Studies Tumor Markers, Biological Risk Receptors, Estrogen Paclitaxel Retrospective Studies Leukemia L1210 Cell Cycle Neoplasm Staging Adenocarcinoma Cell Growth Processes RNA, Small Interfering Mammary Neoplasms, Experimental Immunotherapy, Adoptive Flow Cytometry Registries Prospective Studies Liver Neoplasms Neoplasm Recurrence, Local Disease-Free Survival Tumor Suppressor Protein p53 Down-Regulation Rectal Neoplasms Drug Administration Schedule Cell Transformation, Neoplastic Survivors Risk Assessment Cell Movement United States Prostate-Specific Antigen Transfection Head and Neck Neoplasms

No FAQ available that match "cancer evaluation drug screening assays antitumor"